Showing results (61-70 of 2,089) with videos related to
Sort By:
Pageof 209
Ophtalmologie : Organe De La Societe Francaise D'Ophtalmologie|September 1, 1989
[Dipivefrin: its mechanism of action, clinical efficacy and good tolerance]D G Harper, G D Novack, L R Borrmann, et al.The British Journal of Ophthalmology|December 1, 1988
Levobunolol compared with timolol: a four-year studyO Geyer, M Lazar, G D Novack, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|September 1, 1981
Dipivefrin and echothiophate. Efficacy of combined use in human beingsJ S Mindel, M E Yablonski, H O Tavitian, et al.The American Journal of Physiology|November 1, 1977
Mechanism of production of intestinal secretion by negative luminal pressureA A Hakim, C B Papeleux, J B Lane, et al.Journal of Cutaneous Medicine and Surgery|November 27, 1999
Comparative irritancy study among retinoid creams and gelsJ W Toole, L Lockhart, J Potrebka, et al.Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|July 22, 1998
Bunazosin reduces intraocular pressure in rabbits by increasing uveoscleral outflowG L Zhan, C B Toris, C B Camras, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|March 1, 1985
Levobunolol. A three-month efficacy study in the treatment of glaucoma and ocular hypertensionR E Bensinger, E U Keates, J D Gofman, et al.Klinische Monatsblatter Fur Augenheilkunde|September 1, 1988
[Comparison of the effectiveness and safety of levobunolol and timolol in ocular hypertension and chronic open-angle glaucoma]H Freyler, G D Novack, R Menapace, et al.Journal of Ocular Pharmacology|January 1, 1987
Dihydrolevobunolol is a potent ocular beta-adrenoceptor antagonistD F Woodward, G D Novack, L S Williams, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|August 1, 1983
Topical nylidrin and aqueous humor dynamics in rabbits and monkeysL Sobel, J B Serle, S M Podos, et al.Pageof 209